Literature DB >> 10839996

Possible interference between tissue-non-specific alkaline phosphatase with an Arg54-->Cys substitution and acounterpart with an Asp277-->Ala substitution found in a compound heterozygote associated with severe hypophosphatasia.

M Fukushi-Irié1, M Ito, Y Amaya, N Amizuka, H Ozawa, S Omura, Y Ikehara, K Oda.   

Abstract

Tissue-non-specific alkaline phosphatase (TNSALP) with an Arg(54)-->Cys (R54C) or an Asp(277)-->Ala (D277A)substitution was found in a patient with hypophosphatasia [Henthorn,Raducha, Fedde, Lafferty and Whyte (1992) Proc. Natl. Acad. Sci. U.S.A.89, 9924-9928]. To examine effects of these missense mutations onproperties of TNSALP, the TNSALP mutants were expressed ectopically inCOS-1 cells. The wild-type TNSALP was synthesized as a 66-kDa endo-beta-N-acetylglucosaminidase H (Endo H)-sensitive form, and processed to an 80-kDa mature form, which is anchored to the plasma membrane via glycosylphosphatidylinositol (GPI). Although the mutant proteins were found to be modified by GPI, digestion with phosphatidylinositol-specific phospholipase C, cell-surface biotinylation and immunofluorescence observation demonstrated that the cell-surface appearance of TNSALP (R54C) and TNSALP (D277A) was either almost totally or partially retarded respectively. The 66-kDa Endo H-sensitive band was the only form, and was rapidly degraded in the cells expressing TNSALP (R54C). In contrast with cells expressing TNSALP(R54C), where alkaline phosphatase activity was negligible, significant enzyme activity was detected and, furthermore, the 80-kDa mature form appeared on the surface of the cells expressing TNSALP (D277A). Analysis by sedimentation on sucrose gradients showed that a considerable fraction of newly synthesized TNSALP (R54C) and TNSALP(D277A) formed large aggregates, indicating improper folding and incorrect oligomerization of the mutant enzymes. When co-expressed with TNSALP (R54C), the level of the 80-kDa mature form of TNSALP (D277A)was decreased dramatically, with a concomitant reduction in enzyme activity in the co-transfected cell. These findings suggest that TNSALP(R54C) interferes with folding and assembly of TNSALP (D277A) intrans when expressed in the same cell, thus probably explaining why a compound heterozygote for these mutant alleles developed severe hypophosphatasia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10839996      PMCID: PMC1221107     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

1.  Intracellular protein trafficking defects in human disease.

Authors:  J F Amara; S H Cheng; A E Smith
Journal:  Trends Cell Biol       Date:  1992-05       Impact factor: 20.808

2.  Hypophosphatasia: identification of five novel missense mutations (G507A, G705A, A748G, T1155C, G1320A) in the tissue-nonspecific alkaline phosphatase gene among Japanese patients.

Authors:  M Goseki-Sone; H Orimo; T Iimura; Y Takagi; H Watanabe; K Taketa; S Sato; H Mayanagi; T Shimada; S Oida
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

3.  Detection of deletion 1154-1156 hypophosphatasia mutation using TNSALP exon amplification.

Authors:  H Orimo; M Goseki-Sone; S Sato; T Shimada
Journal:  Genomics       Date:  1997-06-01       Impact factor: 5.736

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Novel missense and frameshift mutations in the tissue-nonspecific alkaline phosphatase gene in a Japanese patient with hypophosphatasia.

Authors:  H Orimo; Z Hayashi; A Watanabe; T Hirayama; T Hirayama; T Shimada
Journal:  Hum Mol Genet       Date:  1994-09       Impact factor: 6.150

6.  Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia.

Authors:  S Narisawa; N Fröhlander; J L Millán
Journal:  Dev Dyn       Date:  1997-03       Impact factor: 3.780

7.  Studies on phosphatidylinositol phosphodiesterase (phospholipase C type) of Bacillus cereus. I. purification, properties and phosphatase-releasing activity.

Authors:  H Ikezawa; M Yamanegi; R Taguchi; T Miyashita; T Ohyabu
Journal:  Biochim Biophys Acta       Date:  1976-11-19

8.  Analysis of liver/bone/kidney alkaline phosphatase mRNA, DNA, and enzymatic activity in cultured skin fibroblasts from 14 unrelated patients with severe hypophosphatasia.

Authors:  M J Weiss; K Ray; M D Fallon; M P Whyte; K N Fedde; M A Lafferty; R A Mulivor; H Harris
Journal:  Am J Hum Genet       Date:  1989-05       Impact factor: 11.025

9.  Seminoma-derived Nagao isozyme is encoded by a germ-cell alkaline phosphatase gene.

Authors:  J L Millán; T Manes
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

10.  Retention and degradation of proteins containing an uncleaved glycosylphosphatidylinositol signal.

Authors:  M C Field; P Moran; W Li; G A Keller; I W Caras
Journal:  J Biol Chem       Date:  1994-04-08       Impact factor: 5.157

View more
  10 in total

1.  Retention at the cis-Golgi and delayed degradation of tissue-non-specific alkaline phosphatase with an Asn153-->Asp substitution, a cause of perinatal hypophosphatasia.

Authors:  Masahiro Ito; Norio Amizuka; Hidehiro Ozawa; Kimimitsu Oda
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

2.  ALPL mutations in adults with rheumatologic disorders and low serum alkaline phosphatase activity.

Authors:  Frank Rauch; Ghalib Bardai; Cheryl Rockman-Greenberg
Journal:  J Bone Miner Metab       Date:  2019-02-04       Impact factor: 2.626

3.  Molecular defect of tissue-nonspecific alkaline phosphatase bearing a substitution at position 426 associated with hypophosphatasia.

Authors:  Hiba A Al-Shawafi; Keiichi Komaru; Kimimitsu Oda
Journal:  Mol Cell Biochem       Date:  2016-12-20       Impact factor: 3.396

4.  Tissue nonspecific alkaline phosphatase is activated via a two-step mechanism by zinc transport complexes in the early secretory pathway.

Authors:  Ayako Fukunaka; Yayoi Kurokawa; Fumie Teranishi; Israel Sekler; Kimimitsu Oda; M Leigh Ackland; Victor Faundez; Makoto Hiromura; Seiji Masuda; Masaya Nagao; Shuichi Enomoto; Taiho Kambe
Journal:  J Biol Chem       Date:  2011-03-14       Impact factor: 5.157

5.  Phenotypic Profiling in Subjects Heterozygous for 1 of 2 Rare Variants in the Hypophosphatasia Gene (ALPL).

Authors:  Daniel R Tilden; Jonathan H Sheehan; John H Newman; Jens Meiler; John A Capra; Andrea Ramirez; Jill Simmons; Kathryn Dahir
Journal:  J Endocr Soc       Date:  2020-06-28

6.  High-molecular intestinal alkaline phosphatase in chronic liver diseases.

Authors:  Kinue Ooi; Katsuya Shiraki; Yoshitaka Morishita; Tsutomu Nobori
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

7.  Hypophosphatasia: a genetic-based nosology and new insights in genotype-phenotype correlation.

Authors:  Etienne Mornet; Agnès Taillandier; Christelle Domingues; Annika Dufour; Emmanuelle Benaloun; Nicole Lavaud; Fabienne Wallon; Nathalie Rousseau; Carole Charle; Mihelaiti Guberto; Christine Muti; Brigitte Simon-Bouy
Journal:  Eur J Hum Genet       Date:  2020-09-24       Impact factor: 4.246

Review 8.  Hypophosphatasia.

Authors:  Etienne Mornet
Journal:  Orphanet J Rare Dis       Date:  2007-10-04       Impact factor: 4.123

9.  Japanese nationwide survey of hypophosphatasia reveals prominent differences in genetic and dental findings between odonto and non-odonto types.

Authors:  Rena Okawa; Kazuma Kokomoto; Taichi Kitaoka; Takuo Kubota; Atsushi Watanabe; Takeshi Taketani; Toshimi Michigami; Keiichi Ozono; Kazuhiko Nakano
Journal:  PLoS One       Date:  2019-10-10       Impact factor: 3.240

10.  NT5E mutations that cause human disease are associated with intracellular mistrafficking of NT5E protein.

Authors:  Michel Fausther; Elise G Lavoie; Jessica R Goree; Giulia Baldini; Jonathan A Dranoff
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.